Liver stones, known medically as hepatolithiasis, are treated through a range of approaches that depend on stone size, location, composition, and whether complications like infection have set in. Options span from oral medication that slowly dissolves certain stones all the way to surgical removal of part of the liver itself. Unlike the more familiar gallstones sitting in the gallbladder, liver stones lodge inside the bile ducts within the liver, which makes them harder to reach and considerably trickier to clear completely.
What Liver Stones Actually Are
Liver stones form inside the intrahepatic bile ducts, the network of small tubes that carry bile through the liver and down toward the intestine. They sit above the junction where the right and left hepatic ducts merge, distinguishing them from common bile duct stones that form lower in the system.1PubMed Central. Hepatolithiasis: Epidemiology, presentation, classification and management of a complex disease Their composition varies. Some are primarily cholesterol-based, while others are pigment stones made largely of calcium bilirubinate. A case report examining stones removed from a patient’s liver found them to be predominantly cholesterol with some bile salts and pigments, and elemental analysis confirmed carbon as the dominant component with no detectable calcium.2International Journal of Surgery Case Reports. A rare presentation of hepatolithiasis in an adolescent patient: A case report Stone composition matters because it determines whether medication can dissolve them or whether physical removal is the only option.
Who Gets Liver Stones and Why
Hepatolithiasis is far more common in East Asia than in Western countries. In Taiwan, South Korea, and mainland China, liver stones account for roughly 20 to 45 percent of all gallstone disease cases, compared to about 1 percent in Western nations.3PubMed. Hepatolithiasis: epidemiology and classification That gap has been narrowing with global migration patterns, and clinicians in Western countries are encountering the condition more frequently than they did a few decades ago.1PubMed Central. Hepatolithiasis: Epidemiology, presentation, classification and management of a complex disease
Several factors drive stone formation. Parasitic liver flukes, particularly Clonorchis sinensis, are a major cause in endemic regions. The adult flukes take up residence in medium and small intrahepatic bile ducts, causing mechanical blockage, chronic inflammation, and scarring around the ducts.4PubMed. Radiologic findings of clonorchiasis That chronic irritation creates conditions ripe for stone formation and a syndrome historically called Oriental cholangiohepatitis, characterized by multiple intrahepatic stones, duct narrowing, and liver abscesses.5PubMed. Biliary lithiasis and helminthiasis The complications of fluke infestation extend beyond stones to include recurrent infections of the bile ducts and, in long-standing cases, bile duct cancer.6PubMed Central. Liver flukes: the malady neglected
Congenital conditions also play a role. Caroli disease, a rare inherited condition that causes the intrahepatic bile ducts to dilate abnormally, leads to bile stasis that predisposes people to both stone formation and repeated bouts of cholangitis.7Clinical Endoscopy. Diffuse-Type Caroli Disease with Characteristic Central Dot Sign Complicated by Multiple Intrahepatic and Common Bile Duct Stones Other causes include previous biliary surgery that altered the anatomy, strictures from prior inflammation, and bile duct abnormalities present from birth.
How Liver Stones Are Diagnosed
Diagnosis typically starts with imaging. Ultrasound is often the first step because it is inexpensive, widely available, and good at spotting dilated ducts. But for a detailed picture of exactly where stones sit within the branching intrahepatic duct system, more advanced imaging is usually needed. MRI combined with a technique called MRCP (magnetic resonance cholangiopancreatography) has become the gold standard for mapping bile duct stones. A study comparing imaging methods for bile duct stones found MRI/MRCP had a sensitivity around 93 percent and a specificity around 92 percent, substantially outperforming CT scans, which had a sensitivity of about 73 percent.8PubMed Central. Comparative Diagnostic Accuracy of Clinical Assessment, Computed Tomography (CT), and Magnetic Resonance Imaging With Magnetic Resonance Cholangiopancreatography (MRI/MRCP) in Evaluating Common Bile Duct Stones The accuracy difference is meaningful when planning treatment, because knowing the precise number, size, and location of intrahepatic stones determines which intervention route makes sense.
CT scanning still has its place, especially in emergency settings where speed matters and MRI is not readily available. Clinical assessment alone, based on symptoms and blood work, catches roughly 71 percent of cases, so imaging is almost always essential for confirming the diagnosis and planning next steps.8PubMed Central. Comparative Diagnostic Accuracy of Clinical Assessment, Computed Tomography (CT), and Magnetic Resonance Imaging With Magnetic Resonance Cholangiopancreatography (MRI/MRCP) in Evaluating Common Bile Duct Stones
Dissolving Stones with Medication
For cholesterol-rich liver stones, ursodeoxycholic acid (UDCA) can sometimes dissolve or shrink them without any procedure at all. UDCA is a naturally occurring bile acid that, when taken orally, shifts bile composition in a way that gradually breaks down cholesterol crystals. In a study of twelve patients with Caroli syndrome and intrahepatic stones, UDCA at doses of 10 to 20 mg per kilogram daily led to sustained improvement in symptoms, normalization of liver function tests, and ultrasound-confirmed dissolution (complete in three patients, partial in nine) over a median follow-up of about four years.9PubMed. Ursodeoxycholic acid treatment of primary hepatolithiasis in Caroli’s syndrome A separate study of children with intrahepatic stones after biliary surgery found that small stones resolved in two out of five patients treated with UDCA.10PubMed Central. Current treatment strategies for postoperative intrahepatic bile duct stones in congenital biliary dilatation: a single center retrospective study
The limitation is that UDCA works slowly and only on cholesterol-dominant stones. Pigment stones, which are more common in cases linked to parasitic infection or chronic biliary inflammation, do not respond to this approach. Even when UDCA does work, it can take months or years to achieve meaningful dissolution, so it is typically reserved for patients with small stones, mild symptoms, or situations where invasive procedures carry unacceptable risk.
Endoscopic Approaches
When medication is not enough, the next step is usually an endoscopic procedure. The workhorse technique is ERCP (endoscopic retrograde cholangiopancreatography), where a flexible scope is passed through the mouth, down through the stomach, and into the opening of the bile duct at the duodenum. From there, instruments can be threaded up into the bile ducts to grab, crush, or flush out stones. Standard ERCP works well for stones in the common bile duct but reaches its limits with stones tucked high up in the intrahepatic ducts.
For difficult stones that resist conventional ERCP, cholangioscopy-guided lithotripsy has become an increasingly important tool. A tiny camera (cholangioscope) is threaded through the ERCP scope directly into the bile ducts, giving the endoscopist a live visual of the stone. Electrohydraulic or laser energy is then delivered through a probe to fragment the stone under direct visualization.11PubMed Central. Cholangioscopy-guided ERCP: expanding diagnostic and therapeutic applications This targeted fragmentation is a significant improvement over blind basket extraction, especially for impacted or very large stones.
Patients with surgically altered anatomy present a special challenge because the normal route to the bile ducts may no longer exist. Balloon-assisted endoscopy can navigate the rearranged intestinal anatomy to reach the biliary opening. A dual-center study using a novel small-caliber cholangioscope in patients with altered anatomy achieved technical success in all 38 cases attempted, with stone fragmentation successful in every lithotripsy case and complete single-session clearance in just over half of patients. Complications occurred in about 8 percent of cases, including minor duct injury and one bowel perforation.12PubMed Central. Efficacy and Safety of Balloon Endoscopy-Assisted Peroral Cholangiopancreatoscopy (POCPS) Using a Novel 9Fr Cholangioscope in Patients With Surgically Altered Anatomy
Percutaneous Access Through the Skin
Sometimes stones cannot be reached from below through the intestine, either because the anatomy has been surgically rearranged or because the stones are too far upstream in the liver’s duct system. In these cases, doctors can go in through the skin. Percutaneous transhepatic cholangioscopy involves inserting a needle through the abdominal wall and into the liver, then gradually dilating that track over several weeks until it is wide enough to pass a small camera and instruments through. Once the track has matured, a video cholangioscope is inserted to visualize the stones directly. Stones can then be flushed into the intestine, grabbed with a basket, or fragmented with lithotripsy, all under direct visualization.
A report on two patients who were not candidates for conventional ERCP described this approach. After emergency biliary drainage through the skin, the access tracts were allowed to mature for six weeks before cholangioscopy and lithotripsy were performed. One patient achieved complete duct clearance in a single session, while the other needed a second procedure to clear remaining intrahepatic stones.13PubMed Central. Percutaneous transhepatic cholangioscopy and lithotripsy in treating difficult biliary ductal stones The two-stage nature of this approach, with weeks between drainage and definitive stone treatment, means it requires patience, but for patients with no other route to the stones it can be the only viable option.
Lithotripsy Technologies for Breaking Up Stones
When stones are too large or too hard to remove intact, they need to be shattered first. Two main energy sources are used for biliary lithotripsy, and they differ in precision and safety profile.
Electrohydraulic lithotripsy (EHL), in clinical use since the early 1980s, delivers shock waves through a probe via electrical discharge in a fluid medium. It remains a cost-effective option and achieves reported success rates of roughly 76 to 88 percent when combined with cholangioscopy.14PubMed Central. Thulium laser-assisted laparoscopic management of intrahepatic stones in recurrent pyogenic cholangitis: A case report and review of minimally invasive approaches The drawback is that EHL disperses energy in all directions, which means it carries a higher risk of injuring the duct wall compared to more focused technologies.15Diagnostic and Interventional Imaging. Percutaneous transhepatic Laser lithotripsy for intrahepatic cholelithiasis
Laser lithotripsy, particularly using Holmium:YAG systems, offers more precision. The laser energy can be delivered through very thin fibers (as narrow as 200 micrometers), allowing it to be aimed precisely at the stone while minimizing damage to surrounding tissue. Success rates for laser lithotripsy in biliary applications reach up to 97 percent.14PubMed Central. Thulium laser-assisted laparoscopic management of intrahepatic stones in recurrent pyogenic cholangitis: A case report and review of minimally invasive approaches Newer laser systems using thulium fiber technology are showing promise as well, with potential advantages in fiber flexibility and energy delivery. Early percutaneous experience with electrohydraulic lithotripsy confirmed it as effective and safe for fragmenting biliary stones and aiding removal.16PubMed. Percutaneous transhepatic cholangioscopic lithotripsy
When Surgery Becomes Necessary
For patients whose stones keep coming back, are concentrated in one part of the liver, or are accompanied by significant duct damage or stricturing, surgery may be the most definitive treatment. The most aggressive surgical option is hepatectomy, removing the portion of the liver containing the diseased ducts and stones. This eliminates both the stones and the damaged tissue that was causing them to form in the first place. A single-center experience with liver resection for primary intrahepatic stones found that over 90 percent of patients had good or fair long-term results, with about three-quarters achieving genuinely good outcomes over a mean follow-up of about five years.17JAMA Surgery. Liver Resection for Primary Intrahepatic Stones: A Single-Center Experience
When resection is not possible because stones are spread across both sides of the liver, surgeons may create a new connection between the bile duct and the intestine (hepaticojejunostomy) to improve bile drainage and allow easier future access for clearing stones. However, this approach has limitations. A retrospective study found that hepaticojejunostomy for hepatolithiasis had a high rate of residual stones and postoperative infection of the bile ducts. The procedure could also make it harder to perform subsequent stone-clearing procedures through a scope.18PubMed Central. Hepaticojejunostomy for hepatolithiasis: a critical appraisal Because of these limitations, surgeons are selective about when they perform this operation.
Laparoscopic approaches, which use small incisions and a camera, are increasingly being used for biliary surgery. A study combining laparoscopy with choledochoscopy (a scope threaded into the bile duct during surgery) for patients with both intrahepatic and extrahepatic stones found that while operating time was longer than the standard open approach, patients had less blood loss, faster recovery of gut function, less need for pain medication, shorter hospital stays, and a lower complication rate of about 7 percent compared to roughly 21 percent with traditional surgery.19PubMed Central. Percutaneous transhepatic cholangioscopy-guided holmium laser lithotripsy for bile duct stones in elderly patients
Managing Cholangitis, the Most Dangerous Complication
The most urgent situation arising from liver stones is acute cholangitis, an infection of the bile ducts caused by blockage and bacterial overgrowth. The classic signs are fever, jaundice, and right-upper-quadrant abdominal pain. When severe, cholangitis can progress rapidly to sepsis and organ failure. Treatment requires three components working together: intravenous fluids, antibiotics, and drainage of the blocked bile duct.20PubMed Central. Acute cholangitis – an update Drainage is the critical step because antibiotics alone cannot sterilize a closed, obstructed system.
The severity of cholangitis also dictates the timing of definitive stone treatment. In moderate to severe cases, the priority is controlling the infection first with drainage, and any stone-clearing procedure is delayed until the infection is under control. In mild cases or patients without active cholangitis, single-session stone removal may be considered after a team assessment of the risks involved.19PubMed Central. Percutaneous transhepatic cholangioscopy-guided holmium laser lithotripsy for bile duct stones in elderly patients Rushing to lithotripsy or surgery while infection is active dramatically increases the risk of septic complications.
The Cancer Risk That Comes with Long-Standing Stones
Hepatolithiasis is an established risk factor for cholangiocarcinoma, a cancer of the bile duct lining. The connection runs through chronic inflammation: stones that sit in the ducts for years cause ongoing irritation and cell turnover, and that persistent proliferative inflammation may drive the molecular changes that lead to malignancy.21PubMed Central. Hepatolithiasis and intrahepatic cholangiocarcinoma: A review This is one of the stronger arguments for treating liver stones proactively rather than watching and waiting, particularly in patients with widespread bilateral disease or recurrent bouts of cholangitis. The risk is not immediate for most patients, but it does make long-term surveillance with periodic imaging and liver function testing an important part of managing the condition. Any new symptoms, unexplained weight loss, or changes on imaging should prompt further investigation.
Why Liver Stones Keep Coming Back
Recurrence is one of the most frustrating aspects of hepatolithiasis. Even after successful stone clearance, stones re-form in a substantial number of patients because the underlying conditions that caused them, such as duct strictures, anatomical abnormalities, or chronic inflammation, often persist. The type of surgery used to improve bile flow affects recurrence rates significantly. When comparing two surgical drainage procedures for patients with recurrent common bile duct stones, one approach (choledochojejunostomy) had a recurrence rate of about 14 percent, while the other (choledochoduodenostomy) saw stones return in roughly two-thirds of patients.
For patients with congenital conditions like Caroli disease, stone recurrence is essentially a lifelong concern. In these cases, management shifts from attempting a one-time cure to establishing a long-term strategy that combines medication (like UDCA for cholesterol stones), periodic imaging surveillance, and a low threshold for repeating endoscopic or percutaneous stone clearance as needed. Patients with recurrent pyogenic cholangitis from parasitic disease may also need antiparasitic treatment alongside stone management to address the root cause.
Diet and General Liver Health
While no specific diet has been proven to dissolve existing liver stones, dietary factors play a background role in liver and biliary health more broadly. Diets rich in fruits, vegetables, whole grains, and lean proteins have been associated with reduced inflammation and oxidative stress in the liver.22International Medical Science Research Journal. Nutritional breakthroughs: Dietary interventions to prevent liver and kidney diseases in the US and Africa Components like omega-3 fatty acids and polyphenols may have protective effects on liver function, though this evidence is general and not specific to hepatolithiasis prevention.
It is worth mentioning what does not work: “liver flushes” or “liver cleanses” involving olive oil and lemon juice (or grapefruit juice, or Epsom salts) that claim to expel liver stones naturally. These regimens circulate widely online, and the waxy lumps that people pass after drinking large amounts of oil are saponified fat, not gallstones or liver stones. No credible clinical evidence supports the idea that these cleanses remove intrahepatic stones. Real liver stones sitting in ducts deep inside the liver cannot be flushed out by anything you swallow. If you have been diagnosed with hepatolithiasis, the treatment options described above, ranging from UDCA to endoscopic or surgical intervention, are what the evidence supports.